ClinicalTrials.gov
ClinicalTrials.gov Menu

Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00180245
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : March 16, 2016
Sponsor:
Information provided by (Responsible Party):
Jörg Kotzerke, Technische Universität Dresden

Brief Summary:
The purpose of the study is to describe the regional and global FDG-kinetics in head and neck cancer during percutaneous radiation therapy.

Condition or disease
Head and Neck Cancer

Study Type : Observational
Actual Enrollment : 44 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : July 2005
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study includes consecutive patients from the Department of Radiooncology with head and neck cancer (HNC) intended for a curative chemoradiotherapy.
Criteria

Inclusion Criteria:

  • Histologically confirmed head and neck cancer not curable by surgery
  • Karnofsky > 70%
  • Tumor volume and localization allow curative radiotherapy
  • Written consent

Exclusion Criteria:

  • Metastases
  • Earlier radiotherapy of head or neck
  • Pregnancy
  • Secondary malignancy excluding dermal carcinoma T1 and Tis-carcinoma of cervix uteri
  • Psychiatric impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00180245


Locations
Germany
Department of Nuclear Medicine
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Principal Investigator: Joerg Kotzerke, MD Department of Nuclear Medicine

Responsible Party: Jörg Kotzerke, Prof. Dr., Technische Universität Dresden
ClinicalTrials.gov Identifier: NCT00180245     History of Changes
Other Study ID Numbers: HNO-FDG-FU
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: March 16, 2016
Last Verified: March 2016

Keywords provided by Jörg Kotzerke, Technische Universität Dresden:
Radiation therapy
F-18-FDG

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms